These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
110 related items for PubMed ID: 24512035
1. Generic initiation and antidepressant therapy adherence under Medicare Part D. Bao Y, Ryan AM, Shao H, Pincus HA, Donohue JM. Am J Manag Care; 2013 Dec; 19(12):989-98. PubMed ID: 24512035 [Abstract] [Full Text] [Related]
2. The effect of the US Medicare Part D coverage gaps on medication use among patients with depression and heart failure. Baik SH, Rollman BL, Reynolds CF, Lave JR, Smith KJ, Zhang Y. J Ment Health Policy Econ; 2012 Sep; 15(3):105-18. PubMed ID: 23001279 [Abstract] [Full Text] [Related]
3. Adherence and persistence to prescribed medication therapy among Medicare part D beneficiaries on dialysis: comparisons of benefit type and benefit phase. Park H, Rascati KL, Lawson KA, Barner JC, Richards KM, Malone DC. J Manag Care Spec Pharm; 2014 Aug; 20(8):862-76. PubMed ID: 25062080 [Abstract] [Full Text] [Related]
4. Effect of the Medicare Part D coverage gap on medication use among patients with hypertension and hyperlipidemia. Li P, McElligott S, Bergquist H, Schwartz JS, Doshi JA. Ann Intern Med; 2012 Jun 05; 156(11):776-84, W-263, W-264, W-265, W-266, W-267, W-268, W-269. PubMed ID: 22665815 [Abstract] [Full Text] [Related]
5. Effects of Medicare Part D coverage gap on medication and medical treatment among elderly beneficiaries with depression. Zhang Y, Baik SH, Zhou L, Reynolds CF, Lave JR. Arch Gen Psychiatry; 2012 Jul 05; 69(7):672-9. PubMed ID: 22752233 [Abstract] [Full Text] [Related]
6. Impact of Medicare Part D on antidepressant treatment, medication choice, and adherence among older adults with depression. Donohue JM, Zhang Y, Aiju M, Perera S, Lave JR, Hanlon JT, Reynolds CF. Am J Geriatr Psychiatry; 2011 Dec 05; 19(12):989-97. PubMed ID: 22123272 [Abstract] [Full Text] [Related]
7. Associations Between Annual Medicare Part D Low-Income Subsidy Loss and Prescription Drug Spending and Use. Fung V, Price M, Cheng D, Patel TA, Yang Z, Hsu J, Alegria M, Newhouse JP. JAMA Health Forum; 2024 Feb 02; 5(2):e235152. PubMed ID: 38306091 [Abstract] [Full Text] [Related]
8. Effects of Medicare Part D coverage gap on medication adherence. Zhang Y, Baik SH, Lave JR. Am J Manag Care; 2013 Jun 01; 19(6):e214-24. PubMed ID: 23844750 [Abstract] [Full Text] [Related]
9. Cost sharing and decreased branded oral anti-diabetic medication adherence among elderly Part D Medicare beneficiaries. Sacks NC, Burgess JF, Cabral HJ, Pizer SD, McDonnell ME. J Gen Intern Med; 2013 Jul 01; 28(7):876-85. PubMed ID: 23404199 [Abstract] [Full Text] [Related]
10. Myopic and Forward Looking Behavior in Branded Oral Anti-Diabetic Medication Consumption: An Example from Medicare Part D. Sacks NC, Burgess JF, Cabral HJ, Pizer SD. Health Econ; 2017 Jun 01; 26(6):753-764. PubMed ID: 27150938 [Abstract] [Full Text] [Related]
11. How Medicare Part D benefit phases affect adherence with evidence-based medications following acute myocardial infarction. Stuart B, Davidoff A, Erten M, Gottlieb SS, Dai M, Shaffer T, Zuckerman IH, Simoni-Wastila L, Bryant-Comstock L, Shenolikar R. Health Serv Res; 2013 Dec 01; 48(6 Pt 1):1960-77. PubMed ID: 23742013 [Abstract] [Full Text] [Related]
12. Patterns of prescription drug expenditures and medication adherence among medicare part D beneficiaries with and without the low-income supplement. Yala SM, Duru OK, Ettner SL, Turk N, Mangione CM, Brown AF. BMC Health Serv Res; 2014 Dec 20; 14():665. PubMed ID: 25526892 [Abstract] [Full Text] [Related]
13. Association of Medicare Part D low-income cost subsidy program enrollment with increased fill adherence to clopidogrel after coronary stent placement. Duru OK, Edgington S, Mangione C, Turk N, Tseng CH, Kimbro L, Ettner S. Pharmacotherapy; 2014 Dec 20; 34(12):1230-8. PubMed ID: 25314343 [Abstract] [Full Text] [Related]
14. Impact of Part D low-income subsidies on medication patterns for Medicare beneficiaries with diabetes. Stuart B, Yin X, Davidoff A, Simoni-Wastila L, Zuckerman I, Shoemaker JS, Doshi J. Med Care; 2012 Nov 20; 50(11):913-9. PubMed ID: 23047779 [Abstract] [Full Text] [Related]
15. The introduction of generic risperidone in Medicare Part D. Fung V, Price M, Busch AB, Landrum MB, Fireman B, Nierenberg AA, Newhouse JP, Hsu J. Am J Manag Care; 2016 Jan 20; 22(1):41-8. PubMed ID: 26799124 [Abstract] [Full Text] [Related]
17. The impact of the introduction of generic aromatase inhibitors on adherence to hormonal therapy over the full course of 5-year treatment for breast cancer. Ma S, Shepard DS, Ritter GA, Martell RE, Thomas CP. Cancer; 2020 Aug 01; 126(15):3417-3425. PubMed ID: 32484941 [Abstract] [Full Text] [Related]
18. The effect of out-of-pocket costs on initiation of disease-modifying therapies among medicare beneficiaries with multiple sclerosis. Hartung DM, Johnston KA, McGregor JC, Bourdette DN. Mult Scler Relat Disord; 2020 Nov 01; 46():102554. PubMed ID: 33032059 [Abstract] [Full Text] [Related]
19. Potential savings associated with drug substitution in Medicare Part D: the Translating Research into Action for Diabetes (TRIAD) study. Duru OK, Ettner SL, Turk N, Mangione CM, Brown AF, Fu J, Simien L, Tseng CW. J Gen Intern Med; 2014 Jan 01; 29(1):230-6. PubMed ID: 23975059 [Abstract] [Full Text] [Related]
20. The relationship between the low-income subsidy and cost-related nonadherence to drug therapies in Medicare Part D. Wei II, Lloyd JT, Shrank WH. J Am Geriatr Soc; 2013 Aug 01; 61(8):1315-23. PubMed ID: 23889465 [Abstract] [Full Text] [Related] Page: [Next] [New Search]